Rilmenidine (Standard)

• Description:

  Rilmenidine (Standard) is the analytical standard of Rilmenidine. This product is intended for research and analytical applications. Rilmenidine, an innovative antihypertensive agent, is an orally active, selective I1 imidazoline receptor agonist. Rilmenidine is an alpha 2-adrenoceptor agonist. Rilmenidine induces autophagy. Rilmenidine acts both centrally by reducing sympathetic overactivity and in the kidney by inhibiting the Na+/H+ antiport. Rilmenidine modulates proliferation and stimulates the proapoptotic protein Bax thus inducing the perturbation of the mitochondrial pathway and apoptosis in human leukemic K562 cells[1][2][3].

• UNSPSC:

  12352005

• Target:

  Adrenergic Receptor; Apoptosis; Autophagy; Imidazoline Receptor; Reference Standards

• Related Pathways:

  Apoptosis; Autophagy; GPCR/G Protein; Neuronal Signaling; Others

• Field of Research:

  Cancer; Cardiovascular Disease

• Smiles:

  C1(NC(C2CC2)C3CC3)=NCCO1

• Molecular Formula:

  C10H16N2O

• Molecular Weight:

  180.25

• References & Citations:

  [1]Reid JL. Rilmenidine: a clinical overview. Am J Hypertens. 2000;13 (6 Pt 2) :106S-111S.|[2]Srdic-Rajic T, et al. Rilmenidine suppresses proliferation and promotes apoptosis via the mitochondrial pathway in human leukemic K562 cells. Eur J Pharm Sci. 2016;81:172-180.|[3]Rose C, et al. Rilmenidine attenuates toxicity of polyglutamine expansions in a mouse model of Huntington's disease. Hum Mol Genet. 2010;19 (11) :2144-2153.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference Standards

• CAS Number:

  54187-04-1